NCT06516588 · Phase 2 · RECRUITING
tDCS for Post-Stroke Cognitive Impairment
This Phase 2 trial is testing whether transcranial direct current stimulation — a mild, non-invasive electrical brain stimulation delivered through scalp electrodes — can improve memory and thinking in people who developed cognitive problems after an ischemic stroke. Phase 2 means researchers are gathering early evidence on whether it works and that it is safe, but it is not a proven or approved treatment. Details beyond the basics are limited.
Eligibility criteria
Inclusion Criteria: 1) ischemic stroke participants in sub-acute phase (at least 10 days after stroke event or discharge and under 5 months post-event) with cognitive dysfunction (MoCA \<26); Exclusion Criteria: 1. clinically significant or unstable medical or psychiatric condition; 2. diagnosis of severe depression; 3. history of relevant neurological diagnosis (e.g., epilepsy); 4. previous neurosurgical procedure with craniectomy; 5. contraindications to tDCS (implanted brain medical devices); 6. severe visual impairment, hearing impairment, aphasia, neglect or dementia.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-10-10